Amygdala acquires Gilead’s candidate for addiction treatment
February 20, 2017Manufacturing and Production, Sales and Marketing Amygdala, Gilead
Amygdala Neurosciences, a biopharmaceutical company that develops and commercialises drugs for the treatment of addiction disorders, has agreed an acquisition …
BlackThorn Therapeutics bring in new CEO
February 20, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BlackThorn Therapeutics
BlackThorn Therapeutics, a biopharmaceutical company that works on developing treatments for neurobehavioral disorders, announced the appointment of Gregory Vontz to …
Generic version of top-selling lung cancer drug hits Chinese market
February 20, 2017Sales and Marketing China, generics
A generic version of AstraZeneca’s Iressa (gefitinib) has been released onto the Chinese market, named Yiruike. The generic undercuts the …
Celgene’s potential blockbuster gets positive Phase 3 results in multiple sclerosis
February 20, 2017Research and Development, Sales and Marketing Celgene, multiple sclerosis
Celgene’s drug to treat patients suffering with relapsing multiple sclerosis (RMS) was given a boost by positive Phase 3 trial …
Cardiovascular disease expected to place $1 trillion cost burden on US
February 20, 2017Medical Communications, Sales and Marketing cardiovascular disease
A study conducted by RTI International, a non-profit research institute, has warned that the US could have to balance over …
AstraZeneca sells off cancer drug to TerSera for $250 million
February 20, 2017Sales and Marketing AstraZeneca, TerSera Therapeutics, Zoladex
AstraZeneca announced that it has sold Zoladex’s (goserelin acetate implant) commercial rights in the US and Canada to TerSera Therapeutics. …
Rise of superbugs in hospitals down to cutting cleaners’ jobs, suggests GMB
February 20, 2017Sales and Marketing GMB, MRSA, NHS, Superbugs
The rising numbers in those exposed to superbugs, such as E.coli and MRSA, is due to the cuts in the …
New Managing Director of UK & Ireland for Novartis
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis
Novartis announced the appointment of Haseeb Ahmad as Managing Director for UK & Ireland. He joins from MSD, known as …
Top Ten most popular articles on Pharmafile.com this week
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
Stories have erupted out of the industry this week with leaps forward in malaria and cancer R&D, some controversial drug …
The future of generic drugs and strategies for commercial success
February 17, 2017Medical Communications generics
GBI Research examines whether the US continue to dominate the global generic drug market.
Zydus Cadila scores twin FDA approvals
February 17, 2017Medical Communications, Sales and Marketing FDA, Zydus Cadila
Indian pharmaceutical firm Zydus Cadila has announced that the US Food and Drug Administration (FDA) has given the go-ahead for …
AstraZeneca’s drug scores positive results against chemo in breast cancer
February 17, 2017Medical Communications, Research and Development AstraZeneca
AstraZeneca announced that its drug, Lynpara (olaparib), had positive results for a recent Phase 3 trial when tested against standard …
Takeda and TiGenix announce successful trial of Crohn’s disease drug
February 17, 2017Medical Communications, Sales and Marketing Takeda, TiGenix
Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601, a treatment for refractory …
What does Trump’s victory mean for the pharma, biotech and healthcare sectors?
February 17, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, Trump
After his first month in office and numerous threats to big pharma, finnCap Life Sciences analysts Alex Pye and Mark …
NICE rejects AbbVie’s leukaemia drug
February 16, 2017Sales and Marketing AbbVie
NICE has rejected AbbVie Venclyxto (venetoclax) for the treatment of chronic lymphocytic leukmaemia, on various grounds but primarily focusing upon …
Malaria vaccine displays 100% success rate in clinical trial
February 16, 2017Research and Development Vaccine, malaria
A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …
Dr Reddy’s rocked by negative patent infringement ruling, shares hit one-year low
February 16, 2017Sales and Marketing Dr Reddy's Laboratories, Helsinn Healthcare
India-based pharmaceutical firm Dr Reddy’s Laboratories has been hit by an unfavourable ruling in a legal case claiming it infringed …
FDA approves Valeant plaque psoriasis drug despite suicide concerns
February 16, 2017Sales and Marketing FDA, Siliq, Valeant, psoriasis
The US Food and Drug Administration (FDA) has announced that it has approved Valeant Pharmaceutical’s injectable psoriasis treatment Siliq (brodalumab) …
Integra bids $1.045 billion for J&J’s neurosurgery business
February 16, 2017Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson
Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …
Woodley Equipment Company Exhibiting at Outsourcing in Clinical Trials West Coast 2017
February 15, 2017Lab Equipment supplier, Medical Equipment Supplier, medical equipment
The Clinical Trials Team at Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast 2017 which is taking place …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
